drugset / Trial / NCT00037752
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
Completed
436 enrolled
University of Tennessee
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.
Timeline
- Start
- 2002-09
- Primary completion
- 2008-08
- Completion
- 2008-08
Publications
- Results DeBon M, Johnson KC, Bush A, and Klesges RC. (2008, March). The efficacy of sibutramine to prevent or decrease post cessation weight gain in overweight and obese smokers. Paper presented at the 29th annual meeting of the Society of Behavioral Medicine, San Diego, CA. March 2008.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sibutramine | Small molecule | 10 mg | — |